Next Article in Journal
Low QRS Voltage and Atrial Fibrillation Precluding Implantation of a Subcutaneous Implantable Cardioverterdefibrillator in a Patient with Arrhythmogenic Cardiomyopathy
Previous Article in Journal
Pompe Disease, a Storage Cardiomyopathy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cardiogenetics
Volume 7
Issue 1
10.4081/cardiogenetics.2017.6882
cardiogenetics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Cardiogenetics is published by MDPI from Volume 10 Issue 2 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Role of Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy

by
Alberto Cipriani
1,
Riccardo Bariani
1,
Manuel De Lazzari
1,
Federico Migliore
1,
Carlo Angheben
2,
Maurizio Del Greco
2,
Domenico Corrado
1,* and
Alessandro Zorzi
1
1
Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy
2
Division of Cardiology, Santa Maria del Carmine Hospital, Rovereto (TN), Italy
*
Author to whom correspondence should be addressed.
Cardiogenetics 2017, 7(1), 6882; https://doi.org/10.4081/cardiogenetics.2017.6882
Submission received: 5 July 2017 / Revised: 4 October 2017 / Accepted: 31 October 2017 / Published: 7 November 2017

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by progressive fibro-fatty replacement of the myocardium that represents the substrate for recurrent sustained ventricular tachycardia (VT). These arrhythmias characterize the clinical course of a sizeable proportion of patients and have significant implications for their quality of life and long-term prognosis. Antiarrhythmic drugs are often poorly tolerated and usually provide incomplete control of arrhythmia relapses. Catheter ablation is a potentially effective strategy to treat frequent VT episodes and ICD shocks in ARVC patients. The aims of this review are to discuss the electrophysiological and electroanatomic substrates of ventricular tachycardia in patients with ARVC and to analyze the role of catheter ablation in their management with particular reference to selection of patients, technical issues, potential complications and outcomes.
Keywords: endocardial voltage mapping; electrophysiology; ventricular tachycardia; sudden death endocardial voltage mapping; electrophysiology; ventricular tachycardia; sudden death

Share and Cite

MDPI and ACS Style

Cipriani, A.; Bariani, R.; De Lazzari, M.; Migliore, F.; Angheben, C.; Del Greco, M.; Corrado, D.; Zorzi, A. Role of Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy. Cardiogenetics 2017, 7, 6882. https://doi.org/10.4081/cardiogenetics.2017.6882

AMA Style

Cipriani A, Bariani R, De Lazzari M, Migliore F, Angheben C, Del Greco M, Corrado D, Zorzi A. Role of Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy. Cardiogenetics. 2017; 7(1):6882. https://doi.org/10.4081/cardiogenetics.2017.6882

Chicago/Turabian Style

Cipriani, Alberto, Riccardo Bariani, Manuel De Lazzari, Federico Migliore, Carlo Angheben, Maurizio Del Greco, Domenico Corrado, and Alessandro Zorzi. 2017. "Role of Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy" Cardiogenetics 7, no. 1: 6882. https://doi.org/10.4081/cardiogenetics.2017.6882

Article Metrics

Back to TopTop